Eisai Co., Ltd. – OTC:ESALF

Eisai Co., Ltd. stock price today

$32.19
+6.54
+25.55%
Financial Health
0
1
2
3
4
5
6
7
8
9

Eisai Co., Ltd. stock price monthly change

-36.31%
month

Eisai Co., Ltd. stock price quarterly change

-36.31%
quarter

Eisai Co., Ltd. stock price yearly change

-48.20%
year

Eisai Co., Ltd. key metrics

Market Cap
16.74B
Enterprise value
1.00T
P/E
35.48
EV/Sales
1.36
EV/EBITDA
15.41
Price/Sales
1.52
Price/Book
1.29
PEG ratio
N/A
EPS
109.41
Revenue
782.57B
EBITDA
63.55B
Income
31.38B
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
4.45%
Oper. margin
3.43%
Gross margin
79.4%
EBIT margin
3.43%
EBITDA margin
8.12%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Eisai Co., Ltd. stock price history

Eisai Co., Ltd. stock forecast

Eisai Co., Ltd. financial statements

Eisai Co., Ltd. (OTC:ESALF): Profit margin
Dec 2021 202.97B 14.15B 6.98%
Mar 2022 190.90B -12.40B -6.5%
Mar 2023 198.20B 16.32B 8.24%
Mar 2024 190.49B 13.30B 6.99%
Eisai Co., Ltd. (OTC:ESALF): Analyst Estimates
2026 746.64B 55.60B 7.45%
2027 783.69B 62.23B 7.94%
2028 866.95B 68.97B 7.96%
2029 949.70B 86.01B 9.06%
  • Analysts Price target

  • Financials & Ratios estimates

4.21%
Yield TTM
Eisai Co., Ltd. (OTC:ESALF): Payout ratio
Payout ratio 140.67%
Eisai Co., Ltd. (OTC:ESALF): Dividend Yield
2020 2.36%
2021 2.02%
2022 2.83%
2023 2.11%
2024 2.63%
Eisai Co., Ltd. (OTC:ESALF): Debt to assets
Sep 2022 1261278000000 410.57B 32.55%
Dec 2022 1251069000000 453.99B 36.29%
Mar 2023 1263350000000 440.77B 34.89%
Mar 2024 1393799000000 494.82B 35.5%
Eisai Co., Ltd. (OTC:ESALF): Cash Flow
Dec 2021 4.76B -10.70B -25.49B
Mar 2022 44.41B -10.18B 4.47B
Mar 2023 23.99B -2.54B -26.44B
Mar 2024 18.05B -2.98B -9.34B

Eisai Co., Ltd. alternative data

Eisai Co., Ltd. (OTC:ESALF): Employee count
Aug 2023 11,076
Sep 2023 11,076
Oct 2023 11,076
Nov 2023 11,076
Dec 2023 11,076
Jan 2024 11,076
Feb 2024 11,076
Apr 2024 11,076
May 2024 11,076
Jun 2024 11,076
Jul 2024 11,067

Eisai Co., Ltd. other data

  • What's the price of Eisai Co., Ltd. stock today?

    One share of Eisai Co., Ltd. stock can currently be purchased for approximately $32.19.

  • When is Eisai Co., Ltd.'s next earnings date?

    Unfortunately, Eisai Co., Ltd.'s (ESALF) next earnings date is currently unknown.

  • Does Eisai Co., Ltd. pay dividends?

    Yes, Eisai Co., Ltd. pays dividends and its trailing 12-month yield is 4.22% with 141% payout ratio.It means that the company is paying a dividend greater than earnings. The last Eisai Co., Ltd. stock dividend of undefined was paid on 7 Sep 2025.

  • How much money does Eisai Co., Ltd. make?

    Eisai Co., Ltd. has a market capitalization of 16.74B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.36% to 741.75B US dollars.

  • What is Eisai Co., Ltd.'s stock symbol?

    Eisai Co., Ltd. is traded on the OTC under the ticker symbol "ESALF".

  • What is Eisai Co., Ltd.'s primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.

  • How do i buy shares of Eisai Co., Ltd.?

    Shares of Eisai Co., Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Eisai Co., Ltd. have?

    As Jul 2024, Eisai Co., Ltd. employs 11,067 workers, which is 0% less then previous month and 0% less then previous quarter.

  • When Eisai Co., Ltd. went public?

    Eisai Co., Ltd. is publicly traded company for more then 14 years since IPO on 7 Apr 2011.

  • What is Eisai Co., Ltd.'s official website?

    The official website for Eisai Co., Ltd. is eisai.co.jp.

  • How can i contact Eisai Co., Ltd.?

    Eisai Co., Ltd. can be reached via phone at +81 3 3817 3700.

Eisai Co., Ltd. company profile:

Eisai Co., Ltd.

eisai.co.jp
Exchange:

OTC

Full time employees:

11,322

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

4-6-10, Koishikawa
Tokyo, 112-8088

:
ISIN: JP3160400002
: